| Literature DB >> 17437629 |
Tina Ruggiero1, Michele Trabucchi, Marco Ponassi, Giorgio Corte, Ching-Yi Chen, Latifa al-Haj, Khalid S A Khabar, Paola Briata, Roberto Gherzi.
Abstract
BACKGROUND: KSRP is a AU-rich element (ARE) binding protein that causes decay of select sets of transcripts in different cell types. We have recently described that phosphatidylinositol 3-kinase/AKT (PI3K-AKT) activation induces stabilization and accumulation of the labile beta-catenin mRNA through an impairment of KSRP function.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17437629 PMCID: PMC1858702 DOI: 10.1186/1471-2199-8-28
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Transcripts whose levels are increased by at least 2 fold in αT3-myrAKT1 when compared with mock-αT3. Transcripts identified as KSRP targets (see Table 3) are typed in bold.
| Transcript name | Accession number | Protein function | Fold increase | |
| 1 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) | NM_006319 | Catalyzes the biosynthesis of phosphatidylinositol. | 3.74 |
| 2 | SNAP91, synaptosomal-associated protein, 91 kDa homolog | NM_014841 | Component of clathrin-coated vescicles. | 3.71 |
| 3 | Solute carrier organic anion transporter family, member 1C1 | NM_017435.2 | Mediates the Na(+)-independent high affinity transport of organic anions such as the thyroid hormones thyroxine (T4) and rT3. | 3.39 |
| 4 | NM_004966 | RNA binding protein, splicing. | 3.20 | |
| 5 | Fibroblast growth factor 5 | NM_004464 | Oncogene, can transform NIH 3T3 cells. | 3.20 |
| 6 | Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | NM_025235.2 | Involved in the regulation of telomere length. | 3.15 |
| 7 | Fibroblast growth factor 19 | NM_005117 | Has a role in brain development, overexpressed in colon adenocarcinoma cell line. | 3.12 |
| 8 | M65028 | RNA binding protein. | 3.11 | |
| 9 | Microtubule-associated protein RP/EB family member 1 | NM_012325 | Component of the microtubule cytoskeleton. | 3.10 |
| 10 | Protocadherin beta 9 | NM_019119 | Calcium-dependent cell-adhesion protein. | 3.00 |
| 11 | NM_002107.3 | Replacement histone, replication independent protein. | 2.96 | |
| 12 | Thyroid hormone receptor interactor 4 | NM_016213 | Transcriptional coactivator of nuclear receptors. | 2.90 |
| 13 | ELL associated factor 2 | NM_018456 | Transcriptional transactivator of ELL and ELL2 elongation activities. | 2.87 |
| 14 | RUN and SH3 domain containing 1 | NM_014328 | Signaling adapter. | 2.86 |
| 15 | Cytochrome c oxidase subunit VIIc | NM_001867 | Component of cytochrome c oxidase. | 2.80 |
| 16 | Zinc finger protein 192 | NM_006298 | Transcriptional regulator. | 2.68 |
| 17 | Notch homolog 3 | NM_000435 | Forms a transcriptional activator complex. | 2.66 |
| 18 | PHD finger protein 12 | NM_001033561 | Transcriptional repressor. | 2.65 |
| 19 | NM_000516 | Guanine nucleotide-binding protein. | 2.60 | |
| 20 | Nascent-polypeptide-associated complex alpha polypeptide | NM_005594 | Prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum. | 2.58 |
| 21 | Protein phosphatase 1, catalytic subunit, beta isoform | NM_002709 | Ser/Thr phosphatase, essential for cell division. | 2.55 |
| 22 | NM_001034955 | Involved in insulin receptor signaling. | 2.51 | |
| 23 | Phosducin-like | NM_005388 | G protein modulator. | 2.51 |
| 24 | Immunoglobulin mu-binding protein 2 | NM_002180.1 | DNA binding protein. | 2.50 |
| 25 | ornithine decarboxylase antizyme 1 | NM_004152 | Destabilizes and promotes degradation of ornithine decarboxylase. | 2.49 |
| 26 | Septin 5 | NM_002688 | Involved in cytokinesis. | 2.44 |
| 27 | epidermal growth factor | NM_001963.2 | Growth factor. | 2.40 |
| 28 | Fibrosin 1 | NM_022452 | Fibrogenic lymphokine. | 2.31 |
| 29 | Death-associated protein kinase 1 | NM_004938 | Pro-apoptotic calcium/calmodulin-dependent serine/threonine kinase. | 2.29 |
| 30 | Caveolin 2 | NM_001233 | Scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. | 2.28 |
| 31 | Dual specificity protein phosphatase 4 | NM_001394 | Regulates mitogenic signal transduction by dephosphorylating both Thr and Tyr residues on MAP kinases ERK1 and ERK2. | 2.14 |
| 32 | Brix domain-containing protein 2 | NM_018321 | Biogenesis of the 60S ribosomal subunit. | 2.07 |
| 33 | NM_007614.2 | Wnt signaling, cell transformation | 2.05 | |
| 34 | NM_002715 | Dephosphorylates several Ser/Thr kinases. | 2.02 | |
| 35 | NM_002136 | RNA binding protein. | 2.00 |
*The regulation of Catenin beta by PI3K-AKT signaling has been described elsewhere [12].
Transcripts whose levels are increased by at least 3 fold upon GST-KSRP chromatography when compared with control GST chromatography.
| Transcript name | Accession number | Fold enrichment | 3'UTR features | Protein functions |
| RAVER2 | NM_018211 | 8.2 | 11 ARE pentamers | RNA-binding protein |
| GNAS1 | NM_000516 | 7.7 | 2 ARE pentamers | Guanine nucleotide -binding protein |
| Protein phosphatase 2A catalytic subunit alpha Isoform (PP2ACA) | NM_002715 | 6.9 | 6 ARE pentamers | Protein phosphatase |
| Sorbin and SH3 domain containing 1 (SORBIN) | NM_001034955 | 6.5 | 11 ARE pentamers | Insulin signaling |
| Histone 3.3A (H3.3A) | NM_002107.3 | 5.9 | 7 ARE pentamers | Nucleosome formation |
| hnRNPF | NM_004966 | 5.6 | 2 ARE pentamers | RNA-binding protein |
| Prothymosin alpha (28) | NM_002823 | 5.5 | 1 ARE pentamer | Transcription factor |
| hnRNPA2/B1 | NM_002137 | 4.7 | 4 ARE pentamers | RNA-binding protein |
| ATP synthase mitochondrial F0 complex subunit G | NM_006476 | 4.1 | 4 ARE pentamers | Mitochondrial ATPase |
| hnRNPA/B | M65028 | 4.0 | 3 ARE pentamers | RNA-binding protein |
| hnRNPA1 | NM_002136 | 4.0 | 2 ARE pentamers | RNA-binding protein |
| Ecotropic viral integration site 5 | NM_005665 | 3.5 | 15 ARE pentamers | Oncogene |
| Catenin beta (CTNN) * | NM_007614.2 | 3.1 | U-rich regions | Transcription/Signaling |
*The interaction of Catenin beta mRNA with KSRP and its decay control have been described in detail elsewhere [12].
Figure 1KSRP associates with a set of unstable mRNAs overrepresented in myrAKT1-αT3-1 cells. (A) In vitro RNA degradation assays using S100 extracts from αT3-1 cells. Internally 32P-labeled, capped RNA substrates (see Additional file 4 for sequences) were incubated with extracts for the indicated times and their decay analyzed as described in Methods. (B) The interaction between 32P-labeled RNAs (indicated on the right) and recombinant purified KSRP (30–300 nM) was evaluated by UV-crosslinking. (C) Immunoprecipitation of ribonucleoprotein complexes containing different KSRP target mRNAs. The proteins were immunoprecipitated from αT3-1 cell extracts using the indicated antibodies. RNA was extracted from the immune complexes and analyzed by RT-PCR as described in Methods.
Figure 3KSRP is required for rapid degradation of a set of unstabletranscripts. (A) Immunoblot analysis of total extracts from either mock-αT3-1 (empty pSUPER-Puro vector-transfected) or αT3-1-shKSRP (pSUPER-Puro-shKSRP-transfected) cells using affinity-purified anti-KSRP and anti-α-tubulin antibodies. (B) Expression of a set of KSRP-interacting mRNAs and β2-MG (as a control), monitored by RT-PCR, in either mock-αT3-1, or αT3-1-shKSRP cells. (C) Semi quantitative RT-PCR analysis of both labile KSRP-associated mRNAs and β2-MG mRNA in either mock-αT3-1 (black lines), or αT3-1-shKSRP cells (red lines). Total RNA was isolated at the indicated times after addition of Actinomycin D. The amount of each transcript was quantitated by densitometry and plotted using a linear regression program. The values shown are averages (± SEM) of three independent experiments performed in duplicates. A quantitation of the transcripts' t(1/2) is presented in Additional file 6.
Figure 2KSRP associates with AUF1p45 and hnRNPA1 in cytoplasmic extracts of aT3-1 cells. (A) S100 extracts from αT3-1 cells were subjected to gel filtration chromatography on a Superose 6 column. Aliquots of the eluted fractions were analyzed by Western blotting using the indicated antibodies. (B) RNase A-treated S100 extracts from αT3-1 cells were immunoprecipitated with preimmune (lane 2) or anti-KSRP (lane 3) sera and analyzed by immunoblotting with either anti-AUF1 (top) or anti-HnRNPA1 (bottom) antibodies. The arrows mark the position of either AUF1p45 or hnRNPA1, while the asterisk marks a anti-AUF1 cross-reacting band. (C) GST-pulldown of either endogenous AUF1p45 (top) or endogenous hnRNPA1 (bottom) from S100 extracts of αT3-1 cells using either control GST or GST-KSRP. Proteins were analyzed by immunoblotting using the indicated antibodies. The arrows mark the position of either AUF1p45 or hnRNPA1.
Molecular partners of KSRP identified by two-hybrid screening.
| hnRNP-A1 | RNA binding protein | P49312 |
| hnRNP-A/B | RNA RNA binding protein | NP_034578 |
| AUF1 p45 | ARE binding protein | NP_031542 |
| PABPN1 | Poly(A) binding protein | XP_214172 |
| eIF2B beta subunit | Translation factor | NP_663420 |
| 14-3-3ζ | Molecular chaperone | NP_035870 |
Figure 4PI3K-AKT signaling stabilizes a set of KSRP-interacting mRNAs and increases their expression. (A) Either mock-αT3-1 or αT3-1-myrAKT1 cells were lysed and total extracts were immunoprecipitated (Ip) with either anti-AKT antibody or control IgG (cIgG). Pellets were incubated (20 min at 30°C) with histone 2B (H2B) in kinase buffer in the presence of γ[32P]ATP under gentle shaking. Labeled proteins were separated by SDS-PAGE and detected by autoradiography. (B) Expression of KSRP-interacting mRNAs and β2-MG (control transcript), monitored by RT-PCR, in either mock-αT3-1 or αT3-1-myrAKT1 cells. (C) Semi quantitative RT-PCR analysis of both KSRP-interacting mRNAs and β2-MG (control transcript) in either mock-αT3-1 (red lines) or αT3-1-myrAKT1 (blue lines). Total RNA was isolated at the indicated times after addition of Actinomycin D. The amount of each transcript was quantitated by densitometry and plotted using a linear regression program. The values shown are averages (± SEM) of three independent experiments performed in duplicates. A quantitation of the transcripts' t(1/2) is presented in Additional file 7.
Figure 5Insulin stabilizes a set of KSRP-interacting mRNAs. (A) Serum-starved HIRc-B cells were treated for 1 h with either PBS (control) or insulin (10-6 M). Total extracts were immunoprecipitated with either anti-AKT antibody or control IgG (cIgG). Pellets were incubated (20 min at 30°C) with histone 2B (H2B) in kinase buffer in the presence of γ[32P]ATP under gentle shaking. Labeled proteins were separated by SDS-PAGE and detected by autoradiography. (B) In vitro RNA degradation assays using S100 extracts from either control or insulin (10-6 M)-treated HIRc-B cells. Internally 32P-labeled, capped RNA substrates (see Additional file 4 for sequences) were incubated with S100 extracts for the indicated times and their decay analyzed as described in Methods.